永赢中证全指医疗器械ETF(159883)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
-10,491,083.26 |
-274,348,130.11 |
-348,412,825.90 |
-295,061,603.09 |
| 利息合计 |
8,504.45 |
2,441,107.71 |
2,010,950.35 |
3,617,237.25 |
| 其中：存款利息收入 |
8,504.45 |
34,009.65 |
20,973.38 |
88,746.74 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-75,129,745.12 |
-263,459,092.45 |
-173,199,053.76 |
-181,978,566.74 |
| 其中：股票投资收益 |
-92,048,098.45 |
-288,376,428.33 |
-186,573,197.12 |
-223,848,838.73 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
16,918,353.33 |
24,917,335.88 |
13,374,143.36 |
41,870,271.99 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
64,299,454.68 |
-17,236,448.02 |
-179,330,292.75 |
-118,835,555.30 |
| 其他收入 |
330,702.73 |
3,906,302.65 |
2,105,570.26 |
2,135,281.70 |
| 费用 |
5,109,257.48 |
10,686,758.97 |
5,508,045.13 |
13,609,892.87 |
| 管理人报酬 |
4,173,501.60 |
8,730,784.56 |
4,500,759.29 |
11,165,114.18 |
| 基金托管费 |
834,700.36 |
1,746,156.98 |
900,151.93 |
2,233,022.82 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
101,055.52 |
201,151.52 |
99,969.67 |
199,053.24 |
| 利润总额 |
-15,600,340.74 |
-285,034,889.08 |
-353,920,871.03 |
-308,671,495.96 |
微信公众号
证券之星APP
基本资料
